FindTrial
Sign In

dose-response relationship of nitroglycerin in the prevention of pituitrin induced hemodynamic response during laparoscopic myomectomy

dose-response relationship of nitroglycerin in the prevention of pituitrin induced hemodynamic response during laparoscopic myomectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062282
Enrollment
Unknown
Registered
2022-07-31
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

group A:50ug nitroglycerin
group B:75ug nitroglycerin
group C:100ug nitroglycerin
group D:125ug nitroglycerin

Sponsors

Jiaxing University Affiliated Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
26 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 26-60 years, ASA ? or ?. 2. Body mass index (BMI) <=35kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Hypertension, diabetes, heart disease; 2. Patients with multiple uterine fibroids (tumor number >=5) or tumor diameter greater than 10cm.

Design outcomes

Primary

MeasureTime frame
Half effective dose and 95% effective dose;Blood pressure;Heart rate;—

Countries

China

Contacts

Public ContactChen Gang

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

chengang120@zju.edu.cn+86 13757118681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026